•
Jun 30, 2022

Seres Therapeutics Q2 2022 Earnings Report

Total Revenue
$1.22M
Previous year: $5.26M
-76.9%
EPS
-$0.7
Previous year: -$0.53
+32.1%
Gross Profit
-$42.7M
Previous year: -$30.7M
+39.2%
Cash and Equivalents
$127M
Previous year: $74M
+71.4%
Free Cash Flow
-$52.1M
Previous year: -$42.2M
+23.2%
Total Assets
$273M
Previous year: $270M
+1.3%

Seres Therapeutics

Seres Therapeutics